Dapsone Tablets, USP
- Manufacturer
- Zydus Lifesciences Limited | Zydus Pharmaceuticals Limited
- Effective date
- 2026-02-27
- Label type
- HUMAN PRESCRIPTION DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 22:07:34
Label at a glance#
Label contents#
Full prescribing information#
DailyMed RxNorm Mappings#
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| DAPSONE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 4ae3f83f-9ccb-db71-5718-0b1e959868df | Product name | 5 | 20260113 |
| 5ae2790a-f798-4a69-8811-64a4723c389a | Product name | 5 | 20250325 |
| b8929bfc-0002-d39a-046d-72ddf714efbe | Product name | 6 | 20190618 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70771-1979-1 | Dapsone | 100 in 1 BOTTLE | TABLET | 100 | 1 | |
| 70771-1979-3 | Dapsone | 30 in 1 BOTTLE | TABLET | 30 | 1 | |
| 70771-1980-1 | Dapsone | 100 in 1 BOTTLE | TABLET | 100 | 1 | |
| 70771-1980-3 | Dapsone | 30 in 1 BOTTLE | TABLET | 30 | 1 |
Products#
Every source-derived product name is available through these pages.
- Dapsone
- MICROCRYSTALLINE CELLULOSE
- CROSCARMELLOSE SODIUM
- HYDROXYPROPYL CELLULOSE, UNSPECIFIED
- SILICON DIOXIDE
- MAGNESIUM STEARATE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 70771-1979 | 70771-1979-1, 70771-1979-3 |
| 70771-1980 | 70771-1980-1, 70771-1980-3 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Orange Book application contexts#
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A220103-001 | DAPSONE | DAPSONE | 25MG | TABLET / ORAL | AB | 2026-02-26 | |
| A220103-002 | DAPSONE | DAPSONE | 100MG | TABLET / ORAL | AB | 2026-02-26 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A220103-001 | AB |
| A220103-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A220103-001 | DAPSONE | 25MG | TABLET / ORAL | AB | 2026-02-26 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A220103-002 | DAPSONE | 100MG | TABLET / ORAL | AB | 2026-02-26 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A220103-001 | DAPSONE | 25MG | TABLET / ORAL | AB | 2026-02-26 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A220103-002 | DAPSONE | 100MG | TABLET / ORAL | AB | 2026-02-26 | caaa826d4ba7… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220103-001 | DAPSONE | 25MG | TABLET / ORAL | AB | 2026-02-26 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220103-002 | DAPSONE | 100MG | TABLET / ORAL | AB | 2026-02-26 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A220103-001 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A220103-002 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A220103-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A220103-002 | AB | 1 | caaa826d4ba7… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220103-001 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220103-002 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dapsone | DAPSONE | Zydus Lifesciences Limited | 1d6bc112-ba2f-40ab-975d-9cfbc853cd11 | 2026-02-27 | 70771-1979-1 70771-1979-3 70771-1980-3 70771-1980-1 70771-1979 70771-1980 70771198001 70771197903 70771198003 70771197901 a4ce6655-3e02-434d-87ad-5bcec90202c1 1d6bc112-ba2f-40ab-975d-9cfbc853cd11 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.

